Literature DB >> 5042374

Clinical biostatistics. XVI. The process of prognostic stratification. 2.

A R Feinstein.   

Abstract

Mesh：

Year:  1972        PMID： 5042374     DOI： 10.1002/cpt1972134609

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  17 in total

1.  Development of a New Clinical Severity Staging System for Patients With Nonmetastatic Papillary Thyroid Carcinoma.

Authors:  Omar A Karadaghy; Dorina Kallogjeri; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-12-01       Impact factor: 6.223

2.  Evaluation of pathologic staging using number of nodes in p16-negative head and neck cancer.

Authors:  Douglas R Farquhar; Andrew J Coniglio; Maheer M Masood; Nicholas Lenze; Paul Brennan; Devasena Anantharaman; Behnoush Abedi-Ardekani; Adam M Zanation; Mark C Weissler; Andrew F Olshan; Siddharth Sheth; Trevor G Hackman
Journal:  Oral Oncol       Date:  2020-05-31       Impact factor: 5.337

3.  Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.

Authors:  Khairuddin Memon; Laura M Kulik; Robert J Lewandowski; Edward Wang; Jonathan Wang; Robert K Ryu; Ryan Hickey; Michael Vouche; Talia Baker; Daniel Ganger; Vanessa L Gates; Ali Habib; Mary F Mulcahy; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2014-03-07       Impact factor: 3.464

4.  A clinicopathological model to predict bone metastasis in hepatocellular carcinoma.

Authors:  Zuo-Lin Xiang; Zhao-Chong Zeng; Jia Fan; Wei-Zhong Wu; Jian He; Hai-Ying Zeng; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-14       Impact factor: 4.553

5.  A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort.

Authors:  Tian Yang; Jin Zhang; Jun-Hua Lu; Li-Qun Yang; Guang-Shun Yang; Meng-Chao Wu; Wei-Feng Yu
Journal:  J Cancer Res Clin Oncol       Date:  2010-07-06       Impact factor: 4.553

6.  Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy.

Authors:  Chia-Yang Hsu; Yun-Hsuan Lee; Yi-Hsiang Huang; Cheng-Yuan Hsia; Chien-Wei Su; Han-Chieh Lin; Rheun-Chuan Lee; Yi-You Chiou; Fa-Yauh Lee; Teh-Ia Huo; Shou-Dong Lee
Journal:  Hepatol Int       Date:  2012-01-08       Impact factor: 6.047

7.  Association of Symptoms and Clinical Findings With Anticipated Outcomes in Patients With Recurrent Head and Neck Cancer.

Authors:  Patrik Pipkorn; Jordan Licata; Dorina Kallogjeri; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-08-01       Impact factor: 6.223

8.  A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.

Authors:  Shu-Yein Ho; Po-Hong Liu; Chia-Yang Hsu; Cheng-Yuan Hsia; Yi-Hsiang Huang; Chien-Wei Su; Hao-Jan Lei; Rheun-Chuan Lee; Ming-Chih Hou; Teh-Ia Huo
Journal:  Dig Dis Sci       Date:  2019-10-28       Impact factor: 3.199

9.  How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?

Authors:  H-N Lin; C-Y Liu; J-T Pai; F-P Chang; C-F Yang; Y-B Yu; L-T Hsiao; T-J Chiou; J-H Liu; J-P Gau; C-H Tzeng; P-M Chen; Y-C Hong
Journal:  Blood Cancer J       Date:  2012-10-12       Impact factor: 11.037

10.  The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma.

Authors:  Akiyoshi Kinoshita; Hiroshi Onoda; Nami Imai; Akira Iwaku; Mutumi Oishi; Ken Tanaka; Nao Fushiya; Kazuhiko Koike; Hirokazu Nishino; Masato Matsushima; Chisato Saeki; Hisao Tajiri
Journal:  BMC Cancer       Date:  2013-02-02       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.